Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
influenza virus mRNA + H2O
?
-
-
-
-
?
pre-rRNA + H2O
mature rRNA
-
enzyme RNase MRP plays an important role in pre-rRNA processing
-
-
?
pre-rRNA + H2O
mature rRNA + 5'-oligonucleotide
-
RNase MRP
-
-
?
pre-tRNA + H2O
?
-
in mitochondria, RNase P function has been taken over by an unrelated, protein-only enzyme activity
-
-
?
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
pre-tRNA precursor + H2O
tRNA + 5'-oligoribonucleotide
SupS1 precursor + H2O
?
-
-
-
-
?
syntaxin18 mRNA + H2O
?
-
-
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
tRNA precursor + H2O
mature tRNA + 5'-terminal oligonucleotide
-
enzyme is responsible for removing the 5'-leader segment of precursor tRNA during maturation
-
-
?
tRNATyr precursor + H2O
mature tRNATyr + 5'-oligonucleotide
-
cleavage of 5'-terminal oligonucleotide, reconstituted mini-enzyme and wild-type enzyme, both cleave at positions G28-G29
generates 5'-phosphate,3'-hydroxyl-product, reconstituted mini-enzyme and wild-type enzyme
-
?
tRNATyrUAG precursor + H2O
?
-
RNase P cleavage of this substrate generates a 5' matured tRNA with a 7 base pair amino acceptor stem
-
-
?
additional information
?
-
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
-
-
-
-
?
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
-
autoantigenic properties of the protein subunits Rpp38 and Rpp30 of catalytically active complexes of human ribonuclease P
-
-
?
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
-
involved in biosynthesis of KB cell tRNA
-
-
?
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
-
RNase P is a key enzyme acting early in the tRNA biogenesis pathway, which catalyses the endonucleolytic cleavage of the 5' leader sequence of precursor tRNAs and generates their 5' mature end
-
-
?
pre-tRNA + H2O
tRNA + 5'-oligoribonucleotide
-
removes 5' extensions from genuine mitochondrial tRNA precursors
-
-
?
pre-tRNA precursor + H2O
tRNA + 5'-oligoribonucleotide
-
-
-
-
?
pre-tRNA precursor + H2O
tRNA + 5'-oligoribonucleotide
-
single endonucleolytic scission in E. coli tRNATyr precursor, thereby separating the 41 extra nucleotides on the 5' end of the precursor molecule from the 5' terminal sequence of the mature tRNATyr molecule
-
-
?
pre-tRNA precursor + H2O
tRNA + 5'-oligoribonucleotide
-
cleaves the precursor to E. coli suppressor tRNATyr at the same site as E. coli RNase P
-
-
?
pre-tRNA precursor + H2O
tRNA + 5'-oligoribonucleotide
-
E. coli tRNATyr precursor
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
5'-leader sequence tRNA processing, essential enzyme
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
cleavage of 5'-terminal oligonucleotide, maturation
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
cleavage of 5'-terminal oligonucleotide, maturation, essential
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
essential enzymes in the biogenesis of tRNA, maturation
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
tRNA processing
-
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
cleavage of 5'-terminal oligonucleotide
generates 5'-phosphate,3'-hydroxyl-product
-
?
tRNA precursor + H2O
mature tRNA + 5'-oligonucleotide
-
cleavage of 5'-terminal oligonucleotide, reconstituted mini-enzyme and wild-type enzyme, both cleave at positions G28-G29
generates 5'-phosphate,3'-hydroxyl-product, reconstituted mini-enzyme and wild-type enzyme
-
?
additional information
?
-
-
biosynthesis and regulation of RNase P, transient interactions with several proteins in the cell, the protein subunits are conserved between RNase P and RNase MRP, and are essential for cell viability and enzyme function, overview, enzyme subunits in nucleolus and Cajal bodies might be involved in cell mitosis and cell-cycle-dependent gene transcription
-
-
?
additional information
?
-
-
coordination of RNA pathways, overview
-
-
?
additional information
?
-
-
protein subunit Rpp20 also acts as an ATPase, protein subunits Rpp14, Rpp21, and Rpp29 are responsible for pre-tRNA substrate binding
-
-
?
additional information
?
-
-
protein subunits Rpp21 and Rpp29 and RNA subunit H1 are sufficient for effective substrate cleavage, thereby the protein subunits facilitate catalytic activity of RNA subunit H1 which requires a phylogenetically conserved pseudoknot-structure for function, protein subunit Rpp29 formsa catalytic complex with M1 RNA from Escherichia coli
-
-
?
additional information
?
-
-
recognition of bipartite substrates and chimera constructed from external guide sequences EGS and ssRNA
-
-
?
additional information
?
-
-
substrate specificities of enzyme forms RNase P and RNase MRP
-
-
?
additional information
?
-
-
the recombinant holoenzyme and the Rpp20p subunit display ATPase activity
-
-
?
additional information
?
-
-
the human mitochondrial RNase P is an entirely protein-based enzyme, protein MRPP1, a probable tRNA methylase, provides tRNA-binding specificity to the RNase P enzyme, protein MRPP2 binds tightly to MRPP1 and is a member of the short chain dehydrogenase/reductase protein family, protein MRPP3 may provide the enzymatic cleavage activity for the patchwork enzyme
-
-
?
additional information
?
-
-
cleavage of target RNA by RNase P is induced when three-fourths of a tRNA is used as an external guide sequence. RNase P enzyme seems to have lost the RNA component during evolution, proving that the catalytic activity of the RNA component of the RNase P holoenzyme can be accomplished by proteins alone. RNase P is able to cleave a model substrate containing only the acceptor stem, a 1 nucleotide (A or C) bulge and the T stem-loop. Cleavage of target RNAs is enhanced if the external guide sequence also contains a variable loop and form a D-like stem with the target, as a minimized 3/4 external guide sequence. Cleaves the internal ribosome entry site region in hepatitis C virus RNA. RNase P-mediated inhibition of mRNAs involved in cancer
-
-
?
additional information
?
-
-
Rpp20 and Rpp25 interact with the P3 arm of RNase MRP RNA in a highly synergic fashion. Rpp20 and Rpp25 interact with the P3 RNA as a heterodimer, which is formed prior to RNA binding
-
-
?
additional information
?
-
-
the natural substrate is precursor tRNA
-
-
?
additional information
?
-
-
the natural substrate is precursor tRNA
-
-
?
additional information
?
-
-
constructed substrate: a hybridized complex of an external guide sequence and a target RNA, e.g. mRNA, that resembles the structure of a tRNA, structure overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Acidosis, Lactic
Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.
Acquired Immunodeficiency Syndrome
Cooperative RNP Assembly: Complementary Rescue of Structural Defects by Protein and RNA Subunits of Archaeal RNase P.
Acute Lung Injury
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Adenocarcinoma of Lung
An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers.
Adenocarcinoma of Lung
Novel 3' ends that support translation.
Atherosclerosis
Complement C5 Protein as a Marker of Subclinical Atherosclerosis.
Atypical Hemolytic Uremic Syndrome
Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.
Autoimmune Diseases
Antibodies in human serum that precipitate ribonuclease P.
Autoimmune Diseases
Characterization of two scleroderma autoimmune antigens that copurify with human ribonuclease P.
Autoimmune Diseases
Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus.
Autoimmune Diseases
RNase MRP and disease.
Autoimmune Diseases
The 40-kilodalton to autoantigen associates with nucleotides 21 to 64 of human mitochondrial RNA processing/7-2 RNA in vitro.
Bone Diseases, Developmental
Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum.
Brain Diseases
RPP25 is developmentally regulated in prefrontal cortex and expressed at decreased levels in autism spectrum disorder.
Breast Neoplasms
Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease P.
Breast Neoplasms
PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer.
Carcinogenesis
NcRNA-microchip analysis: A novel approach to identify differential expression of non-coding RNAs.
Carcinoma
An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers.
Carcinoma, Squamous Cell
An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers.
Cardiomyopathies
Hierarchical RNA Processing Is Required for Mitochondrial Ribosome Assembly.
Cardiomyopathies
Novel patient missense mutations in the HSD17B10 gene affect dehydrogenase and mitochondrial tRNA modification functions of the encoded protein.
Carotid Stenosis
White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition.
Coinfection
A real-time quadriplex PCR assay for the diagnosis of rectal lymphogranuloma venereum and non-lymphogranuloma venereum Chlamydia trachomatis infections.
Colonic Neoplasms
Wnt activated ?-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.
Colorectal Neoplasms
17?-Hydroxysteroid dehydrogenase type 10 predicts survival of patients with colorectal cancer and affects mitochondrial DNA content.
Communicable Diseases
Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.
Connective Tissue Diseases
hPop1: an autoantigenic protein subunit shared by the human RNase P and RNase MRP ribonucleoproteins.
COVID-19
Fast detection of SARS-CoV-2 RNA via the integration of plasmonic thermocycling and fluorescence detection in a portable device.
Cytomegalovirus Infections
RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
Deafness
Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.
Drug Resistant Epilepsy
A novel HSD17B10 mutation impairing the activities of the mitochondrial RNase P complex causes X-linked intractable epilepsy and neurodevelopmental regression.
Dwarfism
The anti-viral protein viperin regulates chondrogenic differentiation via CXCL10 protein secretion.
Epstein-Barr Virus Infections
NcRNA-microchip analysis: A novel approach to identify differential expression of non-coding RNAs.
Foot-and-Mouth Disease
Characterization of a cyanobacterial RNase P ribozyme recognition motif in the IRES of foot-and-mouth disease virus reveals a unique structural element.
Gastroesophageal Reflux
Volume 241, Number 1 (1997), in Article No. RC977772, "A Bidirectional Promoter Connects the p14.5 Gene to the Gene for RNase P and RNase MRP Protein Subunit hPOP1,rdquo; by Gerno Schmiedeknecht, Christa Büchler, and Gerd Schmitz, pages 59-67:
Genetic Diseases, Inborn
RNase MRP and disease.
Genetic Diseases, Inborn
RNase MRP RNA and human genetic diseases.
Glioblastoma
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma.
Glioma
Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms.
Head and Neck Neoplasms
An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers.
Hemoglobinuria
Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.
Hemoglobinuria
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
Hemoglobinuria
Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
Hemoglobinuria
Genetic variants in C5 and poor response to eculizumab.
Hemoglobinuria
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs.
Hemoglobinuria
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Hemoglobinuria, Paroxysmal
Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.
Hemoglobinuria, Paroxysmal
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
Hemoglobinuria, Paroxysmal
Genetic variants in C5 and poor response to eculizumab.
Hemoglobinuria, Paroxysmal
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
Hemoglobinuria, Paroxysmal
Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs.
Hemoglobinuria, Paroxysmal
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
Hepatitis
Inhibition of gene expression by ribozymes.
Hepatitis
Inhibition of nuclear pre-mRNA splicing by antibiotics in vitro.
Hepatitis
Ribozymes in the age of molecular therapeutics.
Hepatitis B
Inhibition of Hepatitis B Virus Gene Expression and Replication by Ribonuclease P.
Hepatitis C
Catalytic RNase P RNA from Synechocystis sp. cleaves the hepatitis C virus RNA near the AUG start codon.
Hepatitis C
Characterization of the structure and variability of an internal region of hepatitis C virus RNA for M1 RNA guide sequence ribozyme targeting.
Hepatitis C
Characterizing the function and structural organization of the 5' tRNA-like motif within the hepatitis C virus quasispecies.
Hepatitis C
Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
Hepatitis C
RNA molecules with structure dependent functions are uniquely folded.
Hepatitis C
Specific cleavage of hepatitis C virus RNA genome by human RNase P.
Herpes Simplex
A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
Herpes Simplex
Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
Herpes Simplex
In vitro selection of external guide sequences for directing RNase P-mediated inhibition of viral gene expression.
Herpes Simplex
Inhibition of viral gene expression by the catalytic RNA subunit of RNase P from Escherichia coli.
Herpes Simplex
Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
Herpes Simplex
RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
Hypersensitivity
Lithium toxicity in yeast is due to the inhibition of RNA processing enzymes.
Infections
Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy.
Infections
Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
Infections
Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
Infections
Insight into the functional role of unique determinants in RNA component of RNase P of Mycobacterium tuberculosis.
Infertility
tRNA processing defects induce replication stress and Chk2-dependent disruption of piRNA transcription.
Influenza, Human
Detection of influenza by real time RT-PCR is not affected by delays in respiratory specimen processing.
Influenza, Human
Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P.
Influenza, Human
Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).
Influenza, Human
Nucleic Acid-Mediated Cleavage of M1 Gene of Influenza A Virus Is Significantly Augmented by Antisense Molecules Targeted to Hybridize Close to the Cleavage Site.
Liver Neoplasms, Experimental
Rat nucleolar 7-2 RNA is homologous to mouse mitochondrial RNase mitochondrial RNA-processing RNA.
Lung Neoplasms
An Immunohistochemical Analysis of a Newly Developed, Mouse Monoclonal p40 (BC28) in Lung, Bladder, Skin, Breast, Prostate, and Head and Neck Cancers.
Lupus Erythematosus, Systemic
Antibodies in human serum that precipitate ribonuclease P.
Lymphogranuloma Venereum
Differentiation of Chlamydia spp. by sequence determination and restriction endonuclease cleavage of RNase P RNA genes.
Measles
[Simultaneous detection of measles and rubella virus by multiplex real-time RT-PCR with an internal control]
Mitochondrial Diseases
Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.
Mitochondrial Diseases
tRNA processing in human mitochondrial disorders.
Mumps
Detection of mumps virus RNA by real-time one-step reverse transcriptase PCR using the LightCycler platform.
Mumps
Real-time reverse transcription-PCR assay for detection of mumps virus RNA in clinical specimens.
Muscle Hypotonia
Recessive Mutations in TRMT10C Cause Defects in Mitochondrial RNA Processing and Multiple Respiratory Chain Deficiencies.
Musculoskeletal Diseases
Utilization of the Department of Defense Peer-Reviewed Orthopaedic Research Program (PRORP): Combating Musculoskeletal Disease With PRORP.
Myasthenia Gravis
Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance.
Mycoplasma Infections
Determination of infectious load of Mycoplasma genitalium in clinical samples of human vaginal cells.
Neoplasms
A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro.
Neoplasms
Cancer in Systemic Sclerosis: Analysis of Antibodies Against Components of the Th/To Complex.
Neoplasms
Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.
Neoplasms
In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.
Neoplasms
Pilot study of combined aerobic and resistance exercise on fatigue for patients with head and neck cancer: Inflammatory and epigenetic changes.
Neoplasms
RPP30, a transcriptional regulator, is a potential pathogenic factor in glioblastoma.
Neoplasms
Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum.
Picornaviridae Infections
Tailoring the switch from IRES-dependent to 5'-end-dependent translation with the RNase P ribozyme.
Pneumonia
Cloning and characterization of the RNase P RNA genes from two porcine mycoplasmas.
Pneumonia
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Prostatic Neoplasms
Investigation on Toxicity and Teratogenicity in Rats of a Retinoid-Polyamine Conjugate with Potent Anti-Inflammatory Properties.
Protein Deficiency
Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.
Protein Deficiency
Structure of the murine fifth complement component (C5) gene. A large, highly interrupted gene with a variant donor splice site and organizational homology with the third and fourth complement component genes.
Psoriasis
Additive inhibitory effect of calcipotriol and anthralin on ribonuclease P activity.
Respiratory Distress Syndrome
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019.
Rheumatic Diseases
Antibodies in human serum that precipitate ribonuclease P.
Rheumatic Diseases
Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.
ribonuclease p deficiency
Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.
ribonuclease p deficiency
Structure of the murine fifth complement component (C5) gene. A large, highly interrupted gene with a variant donor splice site and organizational homology with the third and fourth complement component genes.
ribonuclease p deficiency
Yeast mitochondrial RNase P RNA synthesis is altered in an RNase P protein subunit mutant: insights into the biogenesis of a mitochondrial RNA-processing enzyme.
Rubella
[Simultaneous detection of measles and rubella virus by multiplex real-time RT-PCR with an internal control]
Scleroderma, Systemic
Autoantibodies to a novel Rpp38 (Th/To) derived B-cell epitope are specific for systemic sclerosis and associate with a distinct clinical phenotype.
Scleroderma, Systemic
Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Scleroderma, Systemic
Autoantigenic properties of some protein subunits of catalytically active complexes of human ribonuclease P.
Severe Acute Respiratory Syndrome
Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Smallpox
In search of RNase P RNA from microbial genomes.
Thrombosis
Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.
Tuberculosis
Functional role of putative critical residues in Mycobacterium tuberculosis RNase P protein.
Tuberculosis
Hierarchical Natural Move Monte Carlo Refines Flexible RNA Structures into Cryo-EM Densities.
Tuberculosis
Influence of Conformation of M. tuberculosis RNase P Protein Subunit on Its Function.
Tuberculosis
Inhibition of Bacterial RNase P RNA by Phenothiazine Derivatives.
Tuberculosis
Insight into the functional role of unique determinants in RNA component of RNase P of Mycobacterium tuberculosis.
Tuberculosis
Insight into the role of histidine in RNR motif of protein component of RNase P of M. tuberculosis in catalysis.
Tuberculosis
Phylogenetic comparative mutational analysis of the base-pairing between RNase P RNA and its substrate.
Uterine Cervical Neoplasms
CircASAP1 promotes the development of cervical cancer through sponging miR-338-3p to upregulate RPP25.
Uterine Cervical Neoplasms
LINC00319 promotes migration, invasion and epithelial-mesenchymal transition process in cervical cancer by regulating miR-3127-5p/RPP25 axis.
Uterine Cervical Neoplasms
Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria.
Vaccinia
Analysis of putative RNase P RNA from orthopoxviruses.
Vaccinia
Translation of reovirus RNA species m1 can initiate at either of the first two in-frame initiation codons.
Vesicular Stomatitis
RNA-protein interactions in the human RNase MRP ribonucleoprotein complex.
Virus Diseases
Catalytic M1GS RNA as an antiviral agent in animals.
Virus Diseases
Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
Virus Diseases
RNA polymerase III and antiviral innate immune response.
Virus Diseases
The C5 protein encoded by Ageratum leaf curl Sichuan virus is a virulence factor and contributes to the virus infection.
Whooping Cough
Validation and Implementation of a Diagnostic Algorithm for DNA Detection of Bordetella pertussis, B. parapertussis, and B. holmesii in a Pediatric Referral Hospital in Barcelona, Spain.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
105000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
115000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
13200
-
2 * 16000, full-length Rpp20, gel filtration. 2 * 14100, Rpp20(16-140), gel filtration. 2 * 13200, HisRpp20(35-140), gel filtration
14000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
14100
-
2 * 16000, full-length Rpp20, gel filtration. 2 * 14100, Rpp20(16-140), gel filtration. 2 * 13200, HisRpp20(35-140), gel filtration
15400
-
mutant Rpp25(25-170), gel filtration
16000
-
2 * 16000, full-length Rpp20, gel filtration. 2 * 14100, Rpp20(16-140), gel filtration. 2 * 13200, HisRpp20(35-140), gel filtration
170000
-
rate-zonal sedimentation in linear isokinetic glycerol gradients
20000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
20600
-
mutant Rpp25, gel filtration
20700
-
mutant Rpp25(25-170), sequence analysis
21000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
25000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
26400
-
mutant HisRpp20(35-140), gel filtration
28100
-
mutant Rpp20(16-140), gel filtration
28600
-
mutant Rpp20(35-140)/Rpp25(25-170), gel filtration
29000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
30000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
31100
-
mutant Rpp20(35-140)/Rpp25(25-170), sequence analysis
31500
-
mutant Rpp20/Rpp25(25-170), gel filtration
32100
-
full-length Rpp20, gel filtration
36600
-
mutant Rpp20/Rpp25, gel filtration
38000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
39200
-
mutant Rpp25, sequence analysis
39900
-
mutant HisRpp20(35-140), sequence analysis
40000
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
41100
-
mutant Rpp20/Rpp25(25-170), sequence analysis
44400
-
mutant [Rpp20(35-140)-Rpp25(25-170)]/P3 RNA, gel filtration
45300
-
mutant Rpp20(16-140), sequence analysis
47000
-
full-length Rpp20, sequence analysis
52500
-
mutant [Rpp20-Rpp25]/P3 RNA, gel filtration
53800
-
mutant Rpp20/Rpp25, sequence analysis
56400
-
mutant [Rpp20(35-140)-Rpp25(25-170)]/P3 RNA, sequence analysis
71400
-
mutant [Rpp20-Rpp25]/P3 RNA, sequence analysis
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
heterodimer
-
Rpp20 and Rpp25, ITC-200 microcalorimeter experiments
homodimer
-
2 * 16000, full-length Rpp20, gel filtration. 2 * 14100, Rpp20(16-140), gel filtration. 2 * 13200, HisRpp20(35-140), gel filtration
monomer
-
Rpp25 in solution
oligomer
-
1 * 115000, protein subunit Pop1, + 1 * 40000, protein subunit Rpp40, + 1 * 38000, protein subunit Rpp38, + 1 * 30000, protein subunit Rpp30 or Rpp1, + 1 * 29000, protein subunit Rpp29 or Pop4, + 1 * 25000, protein subunit Rpp25, + 1 * 21000, protein subunit Rpp21 or Rpr2, + 1 * 20000, protein subunit Rpp20 or Pop7 or Rpp2, + 1 * 14000, protein subunit Rpp14, + 1 * 105000, RNA subunit H1
oligomer
-
enzyme is composed of 1 RNA subunit H1 and at least 9 protein subunits, namely Rpp14, Rpp20, Rpp21, Rpp29 i.e. Pop4, Rpp30, Rpp40, Pop1, Pop5, and Rpp25
oligomer
-
subunit composition and interaction, 1 essential RNA subunit, i.e. H1 for RNase P or 7-2 for RNase MRP, plus 9 protein components namely Pop1p, Rpp29p, Rpp20p, Rpp30p, Rep38p, Rpp40p, Rpp25p, and Rpp14p for RNase P, or pls 4 protein components namely Pop1p, Rpp29p, Rpp20p, and Rpp30p for RNase MRP, overview
oligomer
-
subunit composition, 1 RNA subunit, i.e. H1 for RNase P or 7-2 for RNase MRP, plus 9 protein components namely Pop1p, Rpp29p, Rpp20p, Rpp30p, Rep38p, Rpp40p, Rpp25p, and Rpp14p for RNase P, or pls 4 protein components namely Pop1p, Rpp29p, Rpp20p, and Rpp30p for RNase MRP, overview
additional information
-
autoantigenic properties of the protein subunits Rpp38 and Rpp30 of catalytically active complexes of human ribonuclease P
additional information
-
modeling of RNase P holoenzyme assembly, both the mitochondrial and nuclear enzyme complexes are composed of at least 10 protein subunits and 1 RNA subunit H1, overview
additional information
the RNase P complex for 5'-end cleavage comprises the methyltransferase domain-containing protein tRNA methyltransferase 10C, mitochondrial RNase P subunit (TRMT10C/MRPP1), short-chain oxidoreductase hydroxysteroid 17'-dehydrogenase 10 (HSD17B10/MRPP2), and metallonuclease KIAA0391/MRPP3
additional information
-
the RNase P complex for 5'-end cleavage comprises the methyltransferase domain-containing protein tRNA methyltransferase 10C, mitochondrial RNase P subunit (TRMT10C/MRPP1), short-chain oxidoreductase hydroxysteroid 17'-dehydrogenase 10 (HSD17B10/MRPP2), and metallonuclease KIAA0391/MRPP3
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Altman, S.
Ribonuclease P: an enzyme with a catalytic RNA subunit
Adv. Enzymol. Relat. Areas Mol. Biol.
62
1-36
1989
Bos taurus, Escherichia coli, Haloferax volcanii, Homo sapiens
brenda
Pace, N.R.; Smith, D.
Ribonuclease P: function and variation
J. Biol. Chem.
265
3587-3590
1990
Bacillus subtilis, Saccharomyces cerevisiae, Homo sapiens, Schizosaccharomyces pombe, Xenopus laevis
brenda
Gold, H.A.; Altman, S.
Reconstitution of RNAase P activity using inactive subunits from E. coli and HeLa cells
Cell
44
243-249
1986
Escherichia coli, Homo sapiens
brenda
Koski, R.A.; Bothwell, A.L.M.; Altman, S.
Identification of a ribonuclease P-like activity from human KB cells
Cell
9
101-116
1976
Escherichia coli, Homo sapiens
brenda
Doersen, C.J.; Guerrier-Takada, C.; Altman, S.; Attardi, G.
Characterization of an RNase P activity from HeLa cell mitochondria. Comparison with the cytosol RNase P activity
J. Biol. Chem.
260
5942-5949
1985
Homo sapiens
brenda
Jarrous, N.; Eder, P.S.; Guerrier-Takada, C.; Hoog, C.; Altman,S.
Autoantigenic properties of some protein subunits of catalytically active complexes of human ribonuclease P
RNA
4
407-417
1998
Homo sapiens
brenda
Rossmanith, W.; Karwan, R.M.
Characterization of human mitochondrial RNase P: novel aspects in tRNA processing
Biochem. Biophys. Res. Commun.
247
234-241
1998
Homo sapiens
brenda
Xiao, S.; Scott, F.; Fierke, C.A.; Engelke, D.R.
Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes
Annu. Rev. Biochem.
71
165-189
2002
Bacillus subtilis, Saccharomyces cerevisiae, Cyanophora paradoxa, Escherichia coli, Homo sapiens, Methanothermobacter thermautotrophicus, Nicotiana tabacum, Spinacia oleracea
brenda
Gopalan, V.; Vioque, A.; Altman, S.
RNase P: variations and uses
J. Biol. Chem.
277
6759-6762
2002
Aspergillus nidulans, Bacillus subtilis, Saccharomyces cerevisiae, Cyanophora paradoxa, Escherichia coli, Homo sapiens, Leishmania sp., Mus musculus, Trypanosoma sp.
brenda
Xiao, S.; Houser-Scott, F.; Engelke, D.R.
Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway
J. Cell. Physiol.
187
11-20
2001
Bacillus subtilis, Bacteria, Saccharomyces cerevisiae, Cyanophora paradoxa, Homo sapiens, Spinacia oleracea
brenda
Mann, H.; Ben-asouli, Y.; Schein, A.; Moussa, S.; Jarrous, N.
Eukaryotic RNase P: role of RNA and protein subunits of a primordial catalytic ribonucleoprotein in RNA-based catalysis
Mol. Cell
12
925-935
2003
Homo sapiens
brenda
Jarrous, N.
Human ribonuclease P: subunits, function, and intranuclear localization
RNA
8
1-7
2002
Saccharomyces cerevisiae, Homo sapiens
brenda
Guerrier-Takada, C.; Eder, P.S.; Gopalan, V.; Altman, S.
Purification and characterization of Rpp25, an RNA-binding protein subunit of human ribonuclease P
RNA
8
290-295
2002
Homo sapiens
brenda
Bassett, T.; Harpur, B.; Poon, H.Y.; Kuo, K.H.; Lee, C.H.
Effective stimulation of growth in MCF-7 human breast cancer cells by inhibition of syntaxin18 by external guide sequence and ribonuclease P
Cancer Lett.
272
167-175
2008
Homo sapiens
brenda
Walker, S.C.; Engelke, D.R.
A protein-only RNase P in human mitochondria
Cell
135
412-414
2008
Homo sapiens
brenda
Holzmann, J.; Frank, P.; Loeffler, E.; Bennett, K.L.; Gerner, C.; Rossmanith, W.
RNase P without RNA: identification and functional reconstitution of the human mitochondrial tRNA processing enzyme
Cell
135
462-474
2008
Homo sapiens
brenda
Vourekas, A.; Vryzaki, E.; Toumpeki, C.; Stamatopoulou, V.; Monastirli, A.; Tsambaos, D.; Drainas, D.
Partial purification and characterization of RNase P from human peripheral lymphocytes
Exp. Dermatol.
18
130-133
2009
Homo sapiens
brenda
Kirsebom, L.A.; Trobro, S.
RNase P RNA-mediated cleavage
IUBMB Life
61
189-200
2009
Bacillus subtilis, Chlamydia sp., Homo sapiens, no activity in Nanoarchaeum equitans
brenda
Reiner, R.; Krasnov-Yoeli, N.; Dehtiar, Y.; Jarrous, N.
Function and assembly of a chromatin-associated RNase P that is required for efficient transcription by RNA polymerase I
PLoS ONE
3
e4072
2008
Homo sapiens
brenda
Lai, L.B.; Vioque, A.; Kirsebom, L.A.; Gopalan, V.
Unexpected diversity of RNase P, an ancient tRNA processing enzyme: challenges and prospects
FEBS Lett.
584
287-296
2010
Saccharomyces cerevisiae, Escherichia coli, Homo sapiens, Methanothermobacter thermautotrophicus
brenda
Holzmann, J.; Rossmanith, W.
tRNA recognition, processing, and disease: hypotheses around an unorthodox type of RNase P in human mitochondria
Mitochondrion
9
284-288
2009
Homo sapiens
brenda
Lundblad, E.W.; Altman, S.
Inhibition of gene expression by RNase P
New Biotechnol.
27
212-221
2010
Synechocystis sp., Escherichia coli, Homo sapiens, Spinacia oleracea, no activity in Nanoarchaeum equitans, Ignicoccus hospitalis
brenda
Hands-Taylor, K.L.; Martino, L.; Tata, R.; Babon, J.J.; Bui, T.T.; Drake, A.F.; Beavil, R.L.; Pruijn, G.J.; Brown, P.R.; Conte, M.R.
Heterodimerization of the human RNase P/MRP subunits Rpp20 and Rpp25 is a prerequisite for interaction with the P3 arm of RNase MRP RNA
Nucleic Acids Res.
38
4052-4066
2010
Homo sapiens
brenda
Ellis, J.; Brown, J.
The RNase P family
RNA Biol.
6
362-369
2009
Cupriavidus necator, Bacillus subtilis, Saccharomyces cerevisiae, Chlamydia trachomatis, Chlorobium limicola, Escherichia coli, Giardia intestinalis, Homo sapiens, Methanothermobacter thermautotrophicus, Methanocaldococcus jannaschii, Mycoplasmopsis fermentans, Mycoplasma hyopneumoniae, no activity in Aquifex aeolicus, Pyrobaculum aerophilum, Thermomicrobium roseum, Porphyra purpurea, Synechococcus elongatus PCC 6301, Reclinomonas americana
brenda
Marvin, M.C.; Engelke, D.R.
RNase P: increased versatility through protein complexity?
RNA Biol.
6
40-42
2009
Saccharomyces cerevisiae, Homo sapiens
brenda
Jarrous, N.; Gopalan, V.
Archaeal/eukaryal RNase P: subunits, functions and RNA diversification
Nucleic Acids Res.
38
7885-7894
2010
Saccharomyces cerevisiae, [Candida] glabrata, Escherichia coli, Homo sapiens, Methanothermobacter thermautotrophicus, Mus musculus, Mycoplasmopsis fermentans, Pyrococcus furiosus, Saccharolobus solfataricus
brenda
Reiner, R.; Alfiya-Mor, N.; Berrebi-Demma, M.; Wesolowski, D.; Altman, S.; Jarrous, N.
RNA binding properties of conserved protein subunits of human RNase P
Nucleic Acids Res.
39
5704-5714
2011
Homo sapiens
brenda
Howard, M.J.; Liu, X.; Lim, W.H.; Klemm, B.P.; Fierke, C.A.; Koutmos, M.; Engelke, D.R.
RNase P enzymes: divergent scaffolds for a conserved biological reaction
RNA Biol.
10
909-914
2013
Bacillus subtilis, Saccharomyces cerevisiae, Homo sapiens, Thermotoga maritima, Trypanosoma brucei, Ostreococcus tauri, Arabidopsis thaliana (Q66GI4), Arabidopsis thaliana
brenda
Jiang, X.; Chen, Y.C.; Gong, H.; Trang, P.; Lu, S.; Liu, F.
Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences
RNA Biol.
9
1186-1195
2012
Homo sapiens
brenda
Oerum, S.; Roovers, M.; Rambo, R.P.; Kopec, J.; Bailey, H.J.; Fitzpatrick, F.; Newman, J.A.; Newman, W.G.; Amberger, A.; Zschocke, J.; Droogmans, L.; Oppermann, U.; Yue, W.W.
Structural insight into the human mitochondrial tRNA purine N1-methyltransferase and ribonuclease P complexes
J. Biol. Chem.
293
12862-12876
2018
Homo sapiens (O15091), Homo sapiens
brenda
Liu, J.; Shao, L.; Trang, P.; Yang, Z.; Reeves, M.; Sun, X.; Vu, G.P.; Wang, Y.; Li, H.; Zheng, C.; Lu, S.; Liu, F.
Inhibition of herpes simplex virus 1 gene expression and replication by RNase P-associated external guide sequences
Sci. Rep.
6
27068
2016
Homo sapiens (Q99575 AND O95707 AND Q969H6 AND O75817 AND O95059 AND Q9H633 AND Q9BUL9 AND P78346 AND P78345 AND O75818), Homo sapiens
brenda